Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 3Colonic Neoplasms 3Brain Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Nodule 1Stomach Neoplasms 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Mouth Neoplasms 1Melanoma 1Liver Neoplasms 1Intestinal Obstruction 1Intestinal Fistula 1Hypoxia 1Glioma 1Fractures, Bone 1Fibrosis 1Encephalocele 1Colorectal Neoplasms 1Choledochal Cyst 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Brain Tumor Adult 1Abdominal Neoplasms 1

Interventions

TH 302 2Radiotherapy 2pomalidomide 1pimonidazole 1inositol trispyrophosphate 1fluoroazomycin arabinoside 1Thoracotomy 1Thoracic Surgery, Video-Assisted 1Propofol 1Positron Emission Tomography Computed Tomography 1Nimorazole 1Metformin 1Letrozole 1Ipilimumab 1Hydroxychloroquine 1Drug Therapy 1Diagnostic Imaging 1Dexamethasone 1Circulating Tumor DNA 1Bortezomib 1AQ4N 14-methylbenzenesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hypoxia × Propofol × Clear all
NCT04727034 2022-10-12

Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy

RenJi Hospital

Phase NA Unknown
1,800 enrolled
Gastrointestinal

Hypoxia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡